Orchid Pharma Ltd - 524372 - Compliances-Reg.24(A)-Annual Secretarial Compliance
Annual Secretarial Compliance Report for FY 2022-2330-05-2023
Orchid Pharma Ltd - 524372 - Compliances-Reg.24(A)-Annual Secretarial Compliance
Annual Secretarial Compliance Report for FY 2022-23Orchid Pharma Ltd - 524372 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
Announcement under regulation 30 of SEBI (LODR) Regulations, 2015 - Transcript of the Investor callOrchid Pharma Ltd - 524372 - Announcement Under Regulation 30 Of SEBI(LODR) Regulations, 2015 - Updates
Announcement under Regulation 30 of SEBI(LODR) Regulations, 2015 - UpdatesOrchid Pharma Ltd - 524372 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Announcement Under Regulation 30 of SEBI (LODR) - Copy of Newspaper PublicationOrchid Pharma Ltd - 524372 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Outcome/Audio Recording of the Investor CallOrchid Pharma Ltd - 524372 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Investor PresentationOrchid Pharma posts Q4 net profit of 59 crore
The company turned profitable in Q3 FY23 after several quarters of lossesOrchid Pharma Ltd - 524372 - Board Meeting Outcome - Audited Financial Results For Period Ended March 31, 2023
Board Meeting outcome - Audited Financial Results for period ended March 31, 2023